Sybil Tasker

Sybil Tasker currently serves as Chief Medical Officer at Inventprise, a position held since June 2023. Prior to this role, Tasker was Chief Medical Officer at Codagenix, Inc. from July 2019 to June 2023, and at Altimmune, Inc. from April 2016 to July 2019, alongside serving as SVP Clinical R&D at the same company. Tasker also held the position of Senior Director of Clinical Development at Genocea Biosciences, where responsibilities included leading the GEN-003 project. Experience further includes being Executive Medical Director at PRA International and Principal at Tropical & Infectious Disease Resources, LLC, focusing on various aspects of antimicrobial and vaccine development. Earlier in the career, Tasker served as Senior Medical Director at PPD, HIV Program Manager for the US Department of Defense in Africa, and held leadership roles within the US Navy's infectious diseases division. Educational qualifications encompass an AB in Biochemistry from Princeton University, an MD from Columbia University Vagelos College of Physicians and Surgeons, and a Master of Public Health from Johns Hopkins Bloomberg School of Public Health.